International
Available Domestic
Dragon Pharma Klow Blend 80 mg Four-Peptide Research Vial
Injection · 80 mg · vial
Dragon Pharma Klow Blend is one freeze-dried vial that holds 80 mg of material across four repair peptides: BPC-157, TB-500, KPV and GHK-Cu. It is a research material rather than a licensed medicine, and the single 80 mg fill is the only pack option on this page.
GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. Klow Blend for sale with U.S. domestic and international shipping.
Product overview
Dragon Pharma Klow Blend 80 mg Four-Peptide Vial
Klow Blend is a single vial built from four repair-oriented peptides that cover different parts of one job: BPC-157, a fifteen amino acid pentadecapeptide; TB-500, the research name for the acetylated fragment of thymosin beta-4; KPV, the lysine-proline-valine tail of alpha-melanocyte stimulating hormone; and GHK-Cu, the copper-bound tripeptide glycyl-histidyl-lysine. The fixed combination has never been studied in humans, so every compound here is described as it appears in the research literature, and the vial is supplied as laboratory material.
- 80 mg total per lyophilized vial, four peptides in one fill
- Research grade, no approved human indication
- GMP-manufactured and HPLC-verified, COA per batch
- U.S. domestic and international shipping options
How Klow Blend Works
The logic behind the mix is that each peptide has a different target in the same repair picture. BPC-157 is studied in animal models of connective tissue and gut protection; the TB-500 fragment is a structural peptide studied for cell migration; KPV is the piece of the melanocortin hormone credited with its anti-inflammatory signaling, described in the literature as an inhibitor of the NF-kB pathway; and GHK-Cu carries copper into tissue models of remodeling and skin. KPV and GHK-Cu do not substitute for the other two, which is why they sit together in one cake.
Reconstitution & Storage
Add bacteriostatic water down the inside wall of the vial and swirl rather than shake. Divide the fill by the millilitres added: 80 mg with 4 ml gives 20 mg/ml, so 2 mg reads as 0.1 ml or 10 units on a U-100 insulin syringe. Buyers who want the components on their own can order BPC-157 5 mg, TB-500 5 mg, or the copper peptide GHK-Cu as separate vials. Keep the sealed powder at 2-8 C and away from light, and store the mixed solution refrigerated for no more than 30 days. Reported reactions in the peptide literature are mostly local, and any side effects signal at a study dose is not established for this combination.
Quality & Authenticity
Each batch is produced under GMP conditions and checked by HPLC, with a Certificate of Analysis held for the batch. Treat the powder as cold-chain lab material and the mixed vial as short-lived.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Brand | Dragon Pharma |
| Active Substances | BPC-157, TB-500, KPV, GHK-Cu |
| Dosage | 80 mg total per vial |
| Package | 1 lyophilized vial |
| Form | Freeze-dried powder, requires reconstitution |
| Drug Class | Research peptide blend, no approved indication |
| Manufacturing | GMP-certified |
| Testing | HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
FAQ
Before you ask
Questions, answered
One 80 mg lyophilized fill that combines four research peptides: BPC-157, TB-500, KPV and GHK-Cu. Each is a separate molecule with its own literature, and no study has tested the four together. The vial is supplied as laboratory material, not as a medicine for human use.
Add bacteriostatic water slowly down the glass wall and swirl, never shake, because foaming loses peptide. Divide the fill by the water you add: 80 mg with 4 ml makes 20 mg/ml, so 2 mg is 0.1 ml, which reads as 10 units on a U-100 insulin syringe. With 8 ml the same vial is 10 mg/ml and 2 mg becomes 20 units, which is easier to measure if the smaller volume is hard to draw.
The market three-peptide version, usually sold as Glow, is built around GHK-Cu, BPC-157 and TB-500 at a commonly quoted ratio of 5:1:1, and the standard fill for it is 60 mg. Klow adds KPV as a fourth component and the fill grows to 80 mg. The exact weight of each peptide is printed on the label of this vial and is not documented in the project files.
No human safety data exists for the combination, so no side-effect frequency can be quoted. Injection-site reactions are the usual complaint for peptides in this class. The anti-doping position is clearer: BPC-157 is listed in WADA class S0, which is banned at all times, and thymosin beta-4 derivatives such as TB-500 sit in class S2, also permanently prohibited. KPV and GHK-Cu have no direct line in the list.
Keep the sealed powder at 2-8 C, protected from light and moisture, and do not freeze it. Once mixed, hold the solution in the refrigerator and use it within 30 days, avoiding freeze-thaw cycles and discarding anything cloudy. The 80 mg vial is listed with U.S. domestic and international shipping, with price and stock shown against the option selector on this page.
Be the first to share your experience with Dragon Pharma Klow Blend 80 mg Four-Peptide Research Vial
Log in to write a reviewComplete the cycle
Stack it with
International
Available Domestic
International
International